| QUOIN PHARMACEUTICALS |
| USA |
| Gesundheit |
| US74907L4095 / A41BEM |
| 2EB0 (Frankfurt) / QNRX (NASDAQ) |
| FRA:2EB0, ETR:2EB0, 2EB0:GR, NASDAQ:QNRX |
| - |
| https://quoinpharma.com/ |
|
Quoin Pharmaceuticals Ltd. is a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing therapeutic products targeting rare and orphan diseases. Its diversified pro..
>Volltext.. |
| 4.27 Mio. EUR |
| -0.39 Mio. EUR |
| - |
| -12.21 Mio. EUR |
| -11.94 Mio. EUR |
| -404.65 EUR |
| - |
| 1.58 Mio. EUR |
| -9.32 Mio. EUR |
| 0.94 |
| - |
| -58.44% |
| - |
| - |
| - |
| - |
| QUOIN |
| 11.03.26 |
|